Comparison of Newly Proposed LDL-Cholesterol Estimation Equations.
Estimation Equation
Friedewald Equation
Low-Density Lipoprotein Cholesterol
Triglycerides
Journal
Journal of Korean medical science
ISSN: 1598-6357
Titre abrégé: J Korean Med Sci
Pays: Korea (South)
ID NLM: 8703518
Informations de publication
Date de publication:
15 May 2023
15 May 2023
Historique:
received:
11
11
2022
accepted:
01
02
2023
medline:
18
5
2023
pubmed:
16
5
2023
entrez:
16
5
2023
Statut:
epublish
Résumé
Low-density lipoprotein cholesterol is an important marker highly associated with cardiovascular disease. Since the direct measurement of it is inefficient in terms of cost and time, it is common to estimate through the Friedewald equation developed about 50 years ago. However, various limitations exist since the Friedewald equation was not designed for Koreans. This study proposes a new low-density lipoprotein cholesterol estimation equation for South Koreans using nationally approved statistical data. This study used data from the Korean National Health and Nutrition Examination Survey from 2009 to 2019. The 18,837 subjects were used to develop the equation for estimating low-density lipoprotein cholesterol. The subjects included individuals with low-density lipoprotein cholesterol levels directly measured among those with high-density lipoprotein cholesterol, triglycerides, and total cholesterol measured. We compared twelve equations developed in the previous studies and the newly proposed equation (model 1) developed in this study with the actual low-density lipoprotein cholesterol value in various ways. The low-density lipoprotein cholesterol value estimated using the estimation formula and the actual low-density lipoprotein cholesterol value were compared using the root mean squared error. When the triglyceride level was less than 400 mg/dL, the root mean squared of the model 1 was 7.96, the lowest compared to other equations, and the model 2 was 7.82. The degree of misclassification was checked according to the NECP ATP III 6 categories. As a result, the misclassification rate of the model 1 was the lowest at 18.9%, and Weighted Kappa was the highest at 0.919 (0.003), which means it significantly reduced the underestimation rate shown in other existing estimation equations. Root mean square error was also compared according to the change in triglycerides level. As the triglycerides level increased, the root mean square error showed an increasing trend in all equations, but it was confirmed that the model 1 was the lowest compared to other equations. The newly proposed low-density lipoprotein cholesterol estimation equation showed significantly improved performance compared to the 12 existing estimation equations. The use of representative samples and external verification is required for more sophisticated estimates in the future.
Sections du résumé
BACKGROUND
BACKGROUND
Low-density lipoprotein cholesterol is an important marker highly associated with cardiovascular disease. Since the direct measurement of it is inefficient in terms of cost and time, it is common to estimate through the Friedewald equation developed about 50 years ago. However, various limitations exist since the Friedewald equation was not designed for Koreans. This study proposes a new low-density lipoprotein cholesterol estimation equation for South Koreans using nationally approved statistical data.
METHODS
METHODS
This study used data from the Korean National Health and Nutrition Examination Survey from 2009 to 2019. The 18,837 subjects were used to develop the equation for estimating low-density lipoprotein cholesterol. The subjects included individuals with low-density lipoprotein cholesterol levels directly measured among those with high-density lipoprotein cholesterol, triglycerides, and total cholesterol measured. We compared twelve equations developed in the previous studies and the newly proposed equation (model 1) developed in this study with the actual low-density lipoprotein cholesterol value in various ways.
RESULTS
RESULTS
The low-density lipoprotein cholesterol value estimated using the estimation formula and the actual low-density lipoprotein cholesterol value were compared using the root mean squared error. When the triglyceride level was less than 400 mg/dL, the root mean squared of the model 1 was 7.96, the lowest compared to other equations, and the model 2 was 7.82. The degree of misclassification was checked according to the NECP ATP III 6 categories. As a result, the misclassification rate of the model 1 was the lowest at 18.9%, and Weighted Kappa was the highest at 0.919 (0.003), which means it significantly reduced the underestimation rate shown in other existing estimation equations. Root mean square error was also compared according to the change in triglycerides level. As the triglycerides level increased, the root mean square error showed an increasing trend in all equations, but it was confirmed that the model 1 was the lowest compared to other equations.
CONCLUSION
CONCLUSIONS
The newly proposed low-density lipoprotein cholesterol estimation equation showed significantly improved performance compared to the 12 existing estimation equations. The use of representative samples and external verification is required for more sophisticated estimates in the future.
Identifiants
pubmed: 37191848
pii: 38.e145
doi: 10.3346/jkms.2023.38.e145
pmc: PMC10186074
doi:
Substances chimiques
Cholesterol, LDL
0
Triglycerides
0
Cholesterol, HDL
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e145Informations de copyright
© 2023 The Korean Academy of Medical Sciences.
Déclaration de conflit d'intérêts
The authors have no potential conflicts of interest to disclose.
Références
Lipids Health Dis. 2010 May 21;9:52
pubmed: 20487572
Clin Biochem. 2004 Sep;37(9):785-90
pubmed: 15329317
Ann Clin Biochem. 2013 Jan;50(Pt 1):13-9
pubmed: 23108766
Int J Cardiol. 2005 Jun 22;102(1):117-20
pubmed: 15939107
JAMA. 2016 Sep 27;316(12):1289-97
pubmed: 27673306
PLoS One. 2016 Jan 29;11(1):e0148147
pubmed: 26824910
Lipids Health Dis. 2021 Sep 20;20(1):111
pubmed: 34544435
Clin Chem. 1988 Dec;34(12):2532-4
pubmed: 3197296
Clin Chim Acta. 2019 Feb;489:35-40
pubmed: 30448282
JAMA Cardiol. 2020 May 1;5(5):540-548
pubmed: 32101259
Clin Res Cardiol. 2017 Apr;106(4):237-248
pubmed: 28124099
Clin Chem. 2014 Dec;60(12):1519-23
pubmed: 25336719
PLoS One. 2020 Sep 30;15(9):e0239934
pubmed: 32997716
J Am Coll Cardiol. 2019 Jun 25;73(24):3168-3209
pubmed: 30423391
Eur Heart J. 2016 Jul 01;37(25):1944-58
pubmed: 27122601
Lipids Health Dis. 2010 Mar 10;9:27
pubmed: 20219094
JAMA Cardiol. 2018 Aug 1;3(8):749-753
pubmed: 29898218
JAMA. 1986 Nov 7;256(17):2372-7
pubmed: 3464768
Sci Rep. 2021 Jun 29;11(1):13545
pubmed: 34188076
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Jpn Circ J. 1986 Dec;50(12):1191-200
pubmed: 3469420
Front Cardiovasc Med. 2022 Feb 10;9:824574
pubmed: 35224055
Atherosclerosis. 1998 Jun;138(2):289-99
pubmed: 9690912
J Med Assoc Thai. 2009 Feb;92(2):182-7
pubmed: 19253792
JAMA. 2013 Nov 20;310(19):2061-8
pubmed: 24240933
Korean J Fam Med. 2017 Sep;38(5):263-269
pubmed: 29026486
Clin Chim Acta. 2021 Jun;517:108-116
pubmed: 33667481